Health Bulletin 4/July/2022 Roshni Dhar4 July 2022 5:04 PM ISTHere are the Top health Stories for the day:Union Health Minister suspends 2 CGHS doctors for favouring one Pharma company drugsAnnouncing crackdown...
Novavax likely to come up with COVID vaccine targeting Omicron in Q4 Ruchika Sharma3 July 2022 12:30 PM ISTNew Delhi: Novavax Inc said on Friday it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter as it accelerates development...
Oxford Biomedica signs new deal to make AstraZeneca COVID vaccine Ruchika Sharma3 July 2022 12:00 PM ISTOxford: Oxford Biomedica plc, a gene and cell therapy group, has announced that it has signed a new three year Master Services & Development...
Two COVID jabs equally protect people in all body mass groups, says Lancet study Roshni Dhar2 July 2022 3:57 PM ISTAccording to a new study published in The Lancet Diabetes and Endocrinology, vaccines have helped in significantly lowering the number of cases of...
COVID-19: DCGI nod to Gennova's indigenous mRNA vaccine for emergency use in 18 years and above; SII's Covovax for 7-11 years Ruchika Sharma29 Jun 2022 10:00 AM ISTGennova developed the mRNA vaccine with the support of the Department of Biotechnology (DBT) under the Ministry of Science and Technology and its PSU,...
CDSCO panel recommends emergency use nod for Gennova Biopharma mRNA COVID vaccine Ruchika Sharma28 Jun 2022 3:28 PM ISTThe vaccine - GEMCOVAC-19 - is the country's first homegrown mRNA COVID- 19 vaccine and is seen as a game-changer for the healthcare industry.
NTAGI to discuss allowing Biological Corbevax as booster for Covishield, Covaxin recipients Ruchika Sharma28 Jun 2022 9:00 AM ISTCORBEVAX is a protein sub-unit vaccine, developed from a component of the spike protein on the virus's surface, which helps the body build the immune...
Pfizer-BioNTech omicron-adapted COVID vaccines demonstrate high immune response Ruchika Sharma27 Jun 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Sinovac Biotech COVID vaccine CoronaVac conditionally registered in South Africa Ruchika Sharma26 Jun 2022 2:30 PM ISTChina: Sinovac Biotech Ltd. has announced that the South African Health Products Regulatory Authority (SAHPRA) has granted conditional registration to...
Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents Ruchika Sharma26 Jun 2022 12:30 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Valneva COVID vaccine gets marketing authorization in Europe Ruchika Sharma26 Jun 2022 10:00 AM ISTVLA2001 is the whole virus, inactivated, adjuvanted COVID-19 vaccine.
BioNTech in conflict with regulator over new COVID vaccine nod: WAS newspaper Ruchika Sharma25 Jun 2022 1:30 PM ISTThe reason for this was that the approval "should go through the same regulatory process as ordinary flu vaccines", which would allow the new COVID-19...
